Geneos Wealth Management Inc. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2023$15,503
-74.5%
9,7500.0%0.00%
-75.0%
Q4 2022$60,743
-6.5%
9,7500.0%0.00%0.0%
Q3 2022$65,0000.0%9,750
-4.2%
0.00%
+33.3%
Q2 2022$65,000
-55.5%
10,180
-67.7%
0.00%
-50.0%
Q1 2022$146,000
-7.0%
31,5310.0%0.01%0.0%
Q4 2021$157,000
+1470.0%
31,531
+3403.4%
0.01%
Q3 2021$10,000
-44.4%
9000.0%0.00%
-100.0%
Q2 2021$18,000
-25.0%
9000.0%0.00%0.0%
Q1 2021$24,0000.0%9000.0%0.00%0.0%
Q4 2020$24,000
-56.4%
900
-38.8%
0.00%
-66.7%
Q3 2020$55,000
-17.9%
1,4700.0%0.00%
-25.0%
Q2 2020$67,000
+17.5%
1,470
-9.3%
0.00%0.0%
Q1 2020$57,000
+96.6%
1,620
+230.6%
0.00%
+100.0%
Q4 2019$29,000
+38.1%
490
-13.0%
0.00%
+100.0%
Q3 2019$21,000
-19.2%
5630.0%0.00%
-50.0%
Q2 2019$26,000
+18.2%
5630.0%0.00%
+100.0%
Q1 2019$22,000
-8.3%
5630.0%0.00%
-50.0%
Q4 2018$24,000
+14.3%
563
+14.9%
0.00%
+100.0%
Q3 2018$21,000
+133.3%
490
+96.0%
0.00%0.0%
Q2 2018$9,0002500.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders